Velarion Records
Free. Unsubscribe any time.

4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics, Inc. filed 16 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 20 transactions and 364,485 shares. 16 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 10 results prints are on file in the same window.

What stands out

Trades in 4D Molecular Therapeutics, Inc. 20

Adoption dates in 4D Molecular Therapeutics, Inc. 3

Results prints in 4D Molecular Therapeutics, Inc. 10

Trades before a print in 4D Molecular Therapeutics, Inc. 1

Interval to 4D Molecular Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates 4D Molecular Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on June 6, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.